219 related articles for article (PubMed ID: 34593624)
1. Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.
Liu X; Verma A; Garcia G; Ramage H; Lucas A; Myers RL; Michaelson JJ; Coryell W; Kumar A; Charney AW; Kazanietz MG; Rader DJ; Ritchie MD; Berrettini WH; Schultz DC; Cherry S; Damoiseaux R; Arumugaswami V; Klein PS
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34593624
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition.
Liu X; Verma A; Garcia G; Ramage H; Myers RL; Lucas A; Michaelson JJ; Coryell W; Kumar A; Charney AW; Kazanietz MG; Rader DJ; Ritchie MD; Berrettini WH; Schultz DC; Cherry S; Damoiseaux R; Arumugaswami V; Klein PS
medRxiv; 2021 Jul; ():. PubMed ID: 33655282
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication.
Wu CH; Yeh SH; Tsay YG; Shieh YH; Kao CL; Chen YS; Wang SH; Kuo TJ; Chen DS; Chen PJ
J Biol Chem; 2009 Feb; 284(8):5229-39. PubMed ID: 19106108
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Rana AK; Rahmatkar SN; Kumar A; Singh D
Cytokine Growth Factor Rev; 2021 Apr; 58():92-101. PubMed ID: 32948440
[TBL] [Abstract][Full Text] [Related]
5. Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein.
Yun JS; Song H; Kim NH; Cha SY; Hwang KH; Lee JE; Jeong CH; Song SH; Kim S; Cho ES; Kim HS; Yook JI
Mol Cells; 2022 Dec; 45(12):911-922. PubMed ID: 36572560
[TBL] [Abstract][Full Text] [Related]
6. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
7. Lithium and Therapeutic Targeting of GSK-3.
Snitow ME; Bhansali RS; Klein PS
Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
[TBL] [Abstract][Full Text] [Related]
8. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.
Rudd CE
Front Immunol; 2020; 11():1638. PubMed ID: 32695123
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.
Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329
[TBL] [Abstract][Full Text] [Related]
10. Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.
Yaron TM; Heaton BE; Levy TM; Johnson JL; Jordan TX; Cohen BM; Kerelsky A; Lin TY; Liberatore KM; Bulaon DK; Van Nest SJ; Koundouros N; Kastenhuber ER; Mercadante MN; Shobana-Ganesh K; He L; Schwartz RE; Chen S; Weinstein H; Elemento O; Piskounova E; Nilsson-Payant BE; Lee G; Trimarco JD; Burke KN; Hamele CE; Chaparian RR; Harding AT; Tata A; Zhu X; Tata PR; Smith CM; Possemato AP; Tkachev SL; Hornbeck PV; Beausoleil SA; Anand SK; Aguet F; Getz G; Davidson AD; Heesom K; Kavanagh-Williamson M; Matthews DA; tenOever BR; Cantley LC; Blenis J; Heaton NS
Sci Signal; 2022 Oct; 15(757):eabm0808. PubMed ID: 36282911
[TBL] [Abstract][Full Text] [Related]
11. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
12. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of SARS-CoV-2 nucleocapsid protein.
Huang Y; Chen J; Chen S; Huang C; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
Front Cell Infect Microbiol; 2024; 14():1415885. PubMed ID: 38846351
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
[TBL] [Abstract][Full Text] [Related]
15. In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
Hatakeyama D; Masuda T; Miki R; Ohtsuki S; Kuzuhara T
Biochem Biophys Res Commun; 2021 Jun; 557():273-279. PubMed ID: 33894414
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.
Bai Z; Cao Y; Liu W; Li J
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200602
[TBL] [Abstract][Full Text] [Related]
17. Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein.
Supekar NT; Shajahan A; Gleinich AS; Rouhani DS; Heiss C; Chapla DG; Moremen KW; Azadi P
Glycobiology; 2021 Sep; 31(9):1080-1092. PubMed ID: 33997890
[TBL] [Abstract][Full Text] [Related]
18. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.
Carlson CR; Asfaha JB; Ghent CM; Howard CJ; Hartooni N; Safari M; Frankel AD; Morgan DO
Mol Cell; 2020 Dec; 80(6):1092-1103.e4. PubMed ID: 33248025
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
20. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
PLoS Pathog; 2022 Jun; 18(6):e1010627. PubMed ID: 35728038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
